Emergence of vancomycin-resistant enterococci

L B Rice1

  • 1VA Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. louis.rice@med.va.gov

Insights

Certain antibiotics, like cephalosporins, may promote the spread of vancomycin-resistant enterococci (VRE) infections. Understanding how different drugs affect VRE colonization is crucial for effective infection control.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Vancomycin and ampicillin resistance in Enterococcus faecium has emerged as a significant clinical challenge.
  • Strict infection control measures are essential for preventing the spread of resistant pathogens.
  • Emerging evidence suggests a link between specific antimicrobial agents and the dissemination of vancomycin-resistant enterococci (VRE).

Purpose of the Study:

  • To investigate the role of specific antimicrobial classes in the spread and colonization of VRE.
  • To elucidate the mechanisms by which certain antibiotics may promote VRE gastrointestinal colonization.
  • To inform strategies for controlling VRE through a better understanding of drug-induced colonization dynamics.

Main Methods:

  • This study reviews current data and clinical observations regarding antimicrobial use and VRE epidemiology.
  • Analysis focuses on the impact of extended-spectrum cephalosporins and anaerobic antibacterials on VRE.
  • The research examines differential effects on VRE establishment and high-density colonization persistence.

Main Results:

  • Specific antimicrobial classes, notably extended-spectrum cephalosporins, are implicated in promoting VRE infection and colonization.
  • Certain antibiotics may influence the initial establishment and persistence of high-density VRE colonization differently.
  • The findings highlight a potential mechanism linking antibiotic exposure to VRE spread.

Conclusions:

  • Control of VRE necessitates a deeper understanding of how diverse drug classes facilitate gastrointestinal colonization.
  • Antimicrobial stewardship programs should consider the potential VRE-promoting effects of certain antibiotic classes.
  • Further research into drug-host-microbiome interactions is critical for mitigating VRE transmission.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...